Letter to the Editor [1]
dc.authorscopusid | 6701587135 | |
dc.authorscopusid | 6701335627 | |
dc.authorscopusid | 7006785766 | |
dc.authorscopusid | 6506223480 | |
dc.authorscopusid | 20133975300 | |
dc.authorscopusid | 7006640699 | |
dc.contributor.author | Bayramlar H. | |
dc.contributor.author | Hepsen I.F. | |
dc.contributor.author | Ozcan C. | |
dc.contributor.author | Boluk A. | |
dc.contributor.author | Er H. | |
dc.contributor.author | Evereklioglu C. | |
dc.date.accessioned | 2024-08-04T20:02:21Z | |
dc.date.available | 2024-08-04T20:02:21Z | |
dc.date.issued | 1996 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.doi | 10.1111/j.1600-0420.1996.tb00693.x | |
dc.identifier.endpage | 97 | en_US |
dc.identifier.issn | 1395-3907 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 8689494 | en_US |
dc.identifier.scopus | 2-s2.0-0030076276 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 96 | en_US |
dc.identifier.uri | https://doi.org/10.1111/j.1600-0420.1996.tb00693.x | |
dc.identifier.uri | https://hdl.handle.net/11616/91631 | |
dc.identifier.volume | 74 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.relation.ispartof | Acta Ophthalmologica Scandinavica | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | cocaine | en_US |
dc.subject | cocaine | en_US |
dc.subject | eye drops | en_US |
dc.subject | blepharitis | en_US |
dc.subject | cataract | en_US |
dc.subject | chorioretinopathy | en_US |
dc.subject | chromosome 19 | en_US |
dc.subject | clinical article | en_US |
dc.subject | conjunctivitis | en_US |
dc.subject | extraocular muscle | en_US |
dc.subject | eye disease | en_US |
dc.subject | gene mutation | en_US |
dc.subject | human | en_US |
dc.subject | letter | en_US |
dc.subject | muscle hypotonia | en_US |
dc.subject | muscle weakness | en_US |
dc.subject | myotonic dystrophy | en_US |
dc.subject | orbicularis oculi muscle | en_US |
dc.subject | priority journal | en_US |
dc.subject | ptosis | en_US |
dc.subject | pupil disease | en_US |
dc.subject | sympathetic function | en_US |
dc.subject | adrenergic system | en_US |
dc.subject | drug effect | en_US |
dc.subject | genetics | en_US |
dc.subject | innervation | en_US |
dc.subject | iris | en_US |
dc.subject | myotonic dystrophy | en_US |
dc.subject | pathophysiology | en_US |
dc.subject | physiology | en_US |
dc.subject | pupil | en_US |
dc.subject | pupil disease | en_US |
dc.subject | pupil reflex | en_US |
dc.subject | Cocaine | en_US |
dc.subject | Humans | en_US |
dc.subject | Iris | en_US |
dc.subject | Myotonic Dystrophy | en_US |
dc.subject | Ophthalmic Solutions | en_US |
dc.subject | Pupil | en_US |
dc.subject | Pupil Disorders | en_US |
dc.subject | Reflex, Pupillary | en_US |
dc.subject | Sympathetic Nervous System | en_US |
dc.title | Letter to the Editor [1] | en_US |
dc.type | Letter | en_US |